The U.S. health regulator has added new “boxed warnings” to drugs from Pfizer and AbbVie that are part of a class of anti-inflammatory treatments called JAK inhibitors, citing risk of serious health issues and death in some patients, the drugmakers said on Friday. Read More
FDA Adds Strict Safety Warnings on Arthritis Drugs From Pfizer, AbbVie
